Dealings in securities by an associate of directors of Attacq ATTACQ LIMITED (Incorporated in the Republic of South Africa) (Registration number 1997/000543/06) JSE share code: ATT ISIN: ZAE000177218 (“Attacq” or “the company”) DEALINGS IN SECURITIES BY AN ASSOCIATE OF DIRECTORS OF ATTACQ Shareholders are advised of the following information relating to dealings in securities by an associate of directors of Attacq: Name of associate: Attventure (Pty) Ltd of which Mertech Investments (Pty) Ltd (“Mertech”) owns 3%, Johan en Edna Familie Trust (“the Trust”) owns 5.00%, the Suca Trust owns 25% and Fledge Capital (Pty) Ltd (“Fledge Capital”) owns 5%. Names of directors and relationships to directors: PH Faure, who is a director of Attacq and a director of Mertech, which is 21% owned by the Verity Trust of which PH Faure is a trustee and a potential beneficiary, JHP van der Merwe, who is a director of Attacq and trustee and beneficiary of the Trust, LLS van der Watt, who is a director of Attacq and a trustee and beneficiary of the Suca Trust and who is a director and shareholder of Fledge Capital. Transaction date: 5 May 2015 Class of securities: Ordinary shares Number of securities: 305 486 Highest trade price: R24.85 Weighted average price per security: R24.76380 Lowest trade price: R24.56 Total value: R7 564 994.21 Nature of transaction: On-market sale Nature and extent of director’s interest: Indirect beneficial Name of associate: Attventure (Pty) Ltd of which Mertech Investments (Pty) Ltd (“Mertech”) owns 3%, Johan en Edna Familie Trust (“the Trust”) owns 5.00%, the Suca Trust owns 25% and Fledge Capital (Pty) Ltd (“Fledge Capital”) owns 5%. Names of directors and relationships to directors: PH Faure, who is a director of Attacq and a director of Mertech, which is 21% owned by the Verity Trust of which PH Faure is a trustee and a potential beneficiary, JHP van der Merwe, who is a director of Attacq and trustee and beneficiary of the Trust, LLS van der Watt, who is a director of Attacq and a trustee and beneficiary of the Suca Trust and who is a director and shareholder of Fledge Capital. Transaction date: 6 May 2015 Class of securities: Ordinary shares Number of securities: 100 000 Highest trade price: R24.95 Weighted average price per security: R24.61820 Lowest trade price: R24.18 Total value: R2 461 820.00 Nature of transaction: On-market sale Nature and extent of director’s interest: Indirect beneficial Name of associate: Attventure (Pty) Ltd of which Mertech Investments (Pty) Ltd (“Mertech”) owns 3%, Johan en Edna Familie Trust (“the Trust”) owns 5.00%, the Suca Trust owns 25% and Fledge Capital (Pty) Ltd (“Fledge Capital”) owns 5%. Names of directors and relationships to directors: PH Faure, who is a director of Attacq and a director of Mertech, which is 21% owned by the Verity Trust of which PH Faure is a trustee and a potential beneficiary, JHP van der Merwe, who is a director of Attacq and trustee and beneficiary of the Trust, LLS van der Watt, who is a director of Attacq and a trustee and beneficiary of the Suca Trust and who is a director and shareholder of Fledge Capital. Transaction date: 7 May 2015 Class of securities: Ordinary shares Number of securities: 270 000 Highest trade price: R24.81 Weighted average price per security: R24.30300 Lowest trade price: R24.19 Total value: R6 561 810.00 Nature of transaction: On-market sale Nature and extent of director’s interest: Indirect beneficial 8 May 2015 Sponsor Java Capital Date: 08/05/2015 04:43:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.